Drugs giant GlaxoSmithKline issues third quarter figures on Wednesday with the market expecting revenue to decline but earnings to rise.
Revenue is forecast to slide by around 5% to £6,758m from £7,104m the year before, but operating profit is seen climbing to £2,257m from £2,179m.
Earnings per share are tipped to improve to 28.7p from 28.2p in the third quarter of last year, paving the way for a penny-ha'penny increase in the quarterly dividend to 18.5p.
Try 6 free issues of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Start your trial
Sign up for MoneyWeek’s free twice-daily newsletter.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
"As with other pharma companies Glaxo is facing a challenging macro environment and increasing generic competition. This, combined with the discontinuation of
Latest Videos FromMoneyWeek
certain older products, is driving the declining revenue," notes Rae Ellingham at broker Charles Stanley.
Fashion chain Next should have seen third quarter trading and margins boosted by the colder autumnal weather, Peel Hunt reckons.
"We expect third quarter sales to have recovered well over the past seven weeks and expect to see year-to-date Brand sales back at the top end of guidance, up more than 4%, implying third quarter sales growth of 3.8%. We expect management to endorse current guidance and market expectations, although consensus is likely to drift upwards," the broker said.
INTERIMS
Volex
INTERIM DIVIDEND PAYMENT DATE
Amiad Water Systems Ltd, Foresight Solar VCT, Wynnstay Group
INTERIM EX-DIVIDEND DATE
APR Energy, Bloomsbury Publishing, Booker Group, C&C Group, Development Securities, Downing Planned Exit VCT 2 'C' Shares, Downing Planned Exit VCT 2 'D' Shares , Downing Planned Exit VCT 2 'F' Shares, Downing Planned Exit VCT 2011 (General Shares), Downing Planned Exit VCT 2011 (Low Carbon Shares), Downing Planned Exit VCT 2011 (Structured Shares), Downing Planned Exit VCT 3 'C' Shares, Downing Planned Exit VCT 3 'D' Shares , Downing Planned Exit VCT 3 F Shares, Hargreave Hale AIM VCT 2, Hilton Food Group, Howden Joinery Group, Intertek Group, ITV, Laird, Lombard Risk Management, Lookers, M&C Saatchi, Moss Bros Group, Provident Financial, Restore
QUARTERLY PAYMENT DATE
F&C Commercial Property Trust Ltd., JP Morgan Chase & Co, Middlefield Canadian Income PCC, Schroder Income Growth Fund
QUARTERLY EX-DIVIDEND DATE
JPMorgan Claverhouse Inv Trust
INTERNATIONAL ECONOMIC ANNOUNCEMENTS
Chicago PMI (US) (13:45)
Crude Oil Inventories (US) (15:30)
GFK Consumer Confidence (GER) (07:00)
International Reserves (EU) (11:00)
MBA Mortgage Applications (US) (12:00)
Retail Sales (GER) (07:00)
Q3
First Quantum Minerals Ltd., GlaxoSmithKline
FINALS
Neos Resources, Tracsis
ANNUAL REPORT
Aquarius Platinum Ltd.
IMSS
Aegis Group, Barclays, Logica, Mondi, Next, Phoenix Group Holdings (DI), St James's Place, Standard Life
SPECIAL EX-DIVIDEND PAYMENT DATE
IndigoVision Group
EGMS
OSJC Center for Cargo Container Traffic Transcontainer GDR (Reg S)
AGMS
Ashmore Group, Carpathian, Coburg Group, Greenko Group, Ideagen, Pacific Horizon Inv Trust, Tricor
FINAL DIVIDEND PAYMENT DATE
Abbey, Alumasc Group, Haynes Publishing Group, Rank Group
FINAL EX-DIVIDEND DATE
Abcam, AIREA, Allocate Software, El Oro Ltd, Go-Ahead Group, IndigoVision Group, JPMorgan Global Markets Emerging Income Trust
JH
